You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Multidrug treatment for COVID-19
|
|---|---|
| Published in |
Drug Discoveries & Therapeutics, February 2021
|
| DOI | 10.5582/ddt.2021.01005 |
| Pubmed ID | |
| Authors |
Masashi Ohe, Ken Furuya, Houman Goudarzi |
X Demographics
The data shown below were collected from the profiles of 122 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 18 | 15% |
| Netherlands | 5 | 4% |
| France | 4 | 3% |
| United Kingdom | 3 | 2% |
| Canada | 2 | 2% |
| Belgium | 2 | 2% |
| United States | 2 | 2% |
| China | 1 | <1% |
| Unknown | 85 | 70% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 117 | 96% |
| Science communicators (journalists, bloggers, editors) | 4 | 3% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 59 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 7 | 12% |
| Student > Ph. D. Student | 4 | 7% |
| Other | 3 | 5% |
| Student > Doctoral Student | 3 | 5% |
| Researcher | 3 | 5% |
| Other | 11 | 19% |
| Unknown | 28 | 47% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 10% |
| Nursing and Health Professions | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Unspecified | 2 | 3% |
| Other | 8 | 14% |
| Unknown | 30 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 90. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2023.
All research outputs
#487,643
of 25,935,829 outputs
Outputs from Drug Discoveries & Therapeutics
#2
of 297 outputs
Outputs of similar age
#14,420
of 457,075 outputs
Outputs of similar age from Drug Discoveries & Therapeutics
#1
of 3 outputs
Altmetric has tracked 25,935,829 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 297 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 457,075 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them